Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Poynor

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Clinical Pharmacology|March 1, 1987
In consideration of active metabolitesW J Poynor
Pharmaceutical Research|October 1, 1990
Binding of pyrimethamine to human plasma proteins and erythrocytesA C Rudy, W J Poynor
Drug Intelligence & Clinical Pharmacy|May 1, 1983
Comment on aminoglycoside programK W Kolb, W J Poynor
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1980
Pharmacokinetics of saccharin in the rat. Renal clearance in vivo and in the isolated perfused kidneyI Bekersky, W J Poynor, W A Colburn
Journal of Clinical Pharmacology|September 1, 1991
Pharmacokinetic comparison of flurbiprofen in end-stage renal disease subjects and subjects with normal renal functionE A Cefali, W J Poynor, D Sica, et al.
Clinical Pharmacy|November 1, 1984
Single-dose model for predicting steady-state valproic acid serum concentrations in seizure patientsC B Pugh, W R Garnett, W J Poynor, et al.
Clinical Pharmacy|January 1, 1983
Effects of exercise on valproic acid pharmacokineticsT D Marsh, W R Garnett, W J Poynor, et al.
Clinical Pharmacy|November 1, 1987
Single-dose pharmacokinetics of cefuroxime and cefamandole in healthy subjectsP A Colaizzi, S D Goodwin, W J Poynor, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1986
Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral dosesT A Tartaglione, A C Raffalovich, W J Poynor, et al.
Clinical Pharmacy|July 1, 1984
Salicylate removal during plasma exchange in normal volunteersR L White, W R Garnett, W J Poynor, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Clinical Pharmacology|March 1, 1987
In consideration of active metabolitesW J Poynor
Pharmaceutical Research|October 1, 1990
Binding of pyrimethamine to human plasma proteins and erythrocytesA C Rudy, W J Poynor
Drug Intelligence & Clinical Pharmacy|May 1, 1983
Comment on aminoglycoside programK W Kolb, W J Poynor
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1980
Pharmacokinetics of saccharin in the rat. Renal clearance in vivo and in the isolated perfused kidneyI Bekersky, W J Poynor, W A Colburn
Journal of Clinical Pharmacology|September 1, 1991
Pharmacokinetic comparison of flurbiprofen in end-stage renal disease subjects and subjects with normal renal functionE A Cefali, W J Poynor, D Sica, et al.
Clinical Pharmacy|November 1, 1984
Single-dose model for predicting steady-state valproic acid serum concentrations in seizure patientsC B Pugh, W R Garnett, W J Poynor, et al.
Clinical Pharmacy|January 1, 1983
Effects of exercise on valproic acid pharmacokineticsT D Marsh, W R Garnett, W J Poynor, et al.
Clinical Pharmacy|November 1, 1987
Single-dose pharmacokinetics of cefuroxime and cefamandole in healthy subjectsP A Colaizzi, S D Goodwin, W J Poynor, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1986
Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral dosesT A Tartaglione, A C Raffalovich, W J Poynor, et al.
Clinical Pharmacy|July 1, 1984
Salicylate removal during plasma exchange in normal volunteersR L White, W R Garnett, W J Poynor, et al.
Pageof 2